Filter
196
Filtered Results: 196
Text search:
Hunt,
J.
Featured
Recommendations
11
New Publications
32
Language
Document type
No document type
111
Studies & Reports
42
Guidelines
23
Manuals
10
Resource Platforms
4
Training Material
2
Strategic & Response Plan
2
Fact sheets
2
Countries / Regions
Global
11
India
6
South Africa
5
Brazil
5
Syria
4
Western and Central Europe
4
Sierra Leone
3
Philippines
3
Mozambique
3
Indonesia
3
Ukraine
2
USA
2
Africa
2
Germany
2
Uganda
2
Eastern Europe
2
Russia
2
Liberia
2
Colombia
1
Thailand
1
Kenya
1
Ghana
1
China
1
Rwanda
1
Nigeria
1
Peru
1
Malawi
1
Zimbabwe
1
Haiti
1
Cambodia
1
Asia
1
Guinea-Bissau
1
Venezuela
1
Jordan
1
Congo, Democratic Republic of
1
West and Central Africa
1
South–East Asia Region
1
Paraguay
1
Argentina
1
Bangladesh
1
Ethiopia
1
Angola
1
Iraq
1
Ecuador
1
Myanmar / Burma
1
Authors & Publishers
Publication Years
Category
Countries
36
Clinical Guidelines
16
Women & Child Health
13
Public Health
8
Key Resources
5
Pharmacy & Technologies
1
Toolboxes
Mental Health
48
HIV
23
Planetary Health
18
Disability
12
COVID-19
12
Ebola
8
NCDs
8
Caregiver
6
Global Health Education
5
Natural Hazards
4
TB
4
NTDs
4
Rapid Response
3
Conflict
3
Social Ethics
2
Pharmacy
2
Specific Hazards
1
Refugee
1
Polio
1
AMR
1
Guidelines for the management of pregnant and breastfeeding women in the context of Ebola virus disease
recommended
To save the lives of mothers and their babies, mitigate complications, and limit the spread of disease, it is critical that recommendations are made on the prevention, treatment, and surveillance of women who are exposed to EVD, acquire EVD during pregnancy or breastfeeding, or survive EVD with ongo...
Developed by the HHS Panel on Treatment of Pregnant Women with HIV Infection and Prevention of Perinatal Transmission—
A Working Group of the Office of AIDS Research Advisory Council (OARAC)
Accessed: 12.02.2020
Stand 2.10.2020
Вариативные рекомендации 24 сентября 2021 г.
Этот документ представляет собой текущие рекомендации ВОЗ. В них будут вноситься изменения и дополнения,
касающиеся нов...
This paper reviews the effects of vertical responses to COVID-19 on health systems, services, and people’s access to and use of them in LMICs, where historic and ongoing under-investments heighten vulnerability to a multiplicity of health threats. We use the term ‘vertical response’ to describ...
WHO Living guideline: Drugs to prevent COVID-19
recommended
Interim guidance 2 march 2021
Current use of drugs to prevent COVID-19 is variable, reflecting large-scale uncertainty. Numerous randomized trials of many different drugs are underway to inform practice. This first version of the Drugs to prevent COVID-19: A WHO living guideline contains new inform...
3 June 2021. After 40 years of AIDS, charting a course to end the pandemic.
The report shows that countries with progressive laws and policies and strong and inclusive health systems have had the best outcomes against HIV. In those countries, people living with and affected by HIV are more likely t...
The goal of this best practice guideline is to strengthen collaborative practice among nurses, because effective collaborative practice is essential for working in health-care organizations.
In this guideline, we focus on collaborative practice amongst three types of nursing professionals – reg...
MAMI refers to the management of small and nutritionally at risk infants under six months of age (infants u6m) and their mothers.
WHO’s antiretroviral treatment (ART) clinic-based acquired drug resistance survey method yields robust estimates of HIV viral suppression and acquired HIV drug resistance in adults, children and adolescents taking both dolutegravir and non-dolutegravir based regimens.
Results are used to inform A...
Esta primeira versão de Medicamentos para prevenção da COVID-19: Orientação dinâmica da OMS aborda o uso de hidroxicloroquina para prevenção da COVID-19. Segue-se a publicação de uma análise sistemática e NMA que reuniu dados de seis estudos com 6.059 participantes que não tinham COVID-...
As countries commit to achieving universal health coverage, it is imperative to ensure that the design and delivery of palliative care services place attention on quality of care, with action needed across all domains of quality health services: effectiveness, safety, people-centredness, timeliness,...
Access to controlled medicines. 3rd edition
Consolidated recommendations for palliative care in the SARS pandemic-Cov-2/COVID-19 2020
Resumo: o que é esta orientação dinâmica?
Pergunta clínica: qual é o papel dos medicamentos na prevenção da COVID-19?
Público-alvo: o público-alvo são os médicos e os tomadores de decisão na área da saúde.
Prática atual: o uso atual de medicamentos para prevenção da COVID-19 é ...
Groupe d'étude sur la douleur et les politiques / Centre collaborateur de l'OMS pour les politiques de soulagement de la douleur et de soins palliatifs
This report - the largest of its kind to date - draws on the experiences of over 8,500 women and 300 health professionals across eight countries. It exposes the aggressive marketing practices used by the formula milk industry, and highlights impacts on families’ decisions about how to feed their b...
The emergence and transmission of zoonotic diseases are driven by complex interactions
between health, environmental, and socio-political systems. Human movement is considered
a significant and increasing factor in these processes, yet forced migration remains an
understudied area of zoonotic res...
BackgroundClimate change is one of the great challenges of our time. The consequences of climate change on exposed biological subjects, as well as on vulnerable societies, are a concern for the entire scientific community. Rising temperatures, heat waves, floods, tornadoes, hurricanes, droughts, fir...
